Andy Eberding
Impact in
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
- Apelin-related biomedical research
Papers in
-
- Ginseng Biological Effects and Applications 4
- Natural product bioactivities and synthesis 2
- Biological Activity of Diterpenoids and Biflavonoids 1
- Medicinal Plants and Bioactive Compounds 1
- Plant-derived Lignans Synthesis and Bioactivity 1
- Oncology 1
- Co-authors
- Emma S. Tomlinson Guns (6 shared papers)G.H.N. Towers (2 shared papers)Dong Sheng Ming (2 shared papers)William Jia (4 shared papers)Ladan Fazli (4 shared papers)Catherine A. Wood (4 shared papers)Emma Tomlinson Guns (3 shared papers)Hans Adomat (4 shared papers)
- Journals
- The Journal of Urology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Phytotherapy Research (1 paper)Analytical Biochemistry (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- CanadaGermanyNew Zealand
In The Last Decade
Andy Eberding
10 papers receiving 348 citations
Peers
Comparison fields: 5 of 58
- Pharmacology 138
- Complementary and alternative medicine 42
- Molecular Biology 281
- Pharmacology 42
- Endocrinology, Diabetes and Metabolism 35
Countries citing papers authored by Andy Eberding
This map shows the geographic impact of Andy Eberding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Eberding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Eberding more than expected).
Fields of papers citing papers by Andy Eberding
This network shows the impact of papers produced by Andy Eberding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Eberding. The network helps show where Andy Eberding may publish in the future.
Co-authors
The 22 scholars most cited alongside Andy Eberding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 102 | |
| 2 | 2006 | 56 | |
| 3 | 2005 | 51 | |
| 4 | 2009 | 44 | |
| 5 | 2012 | 33 | |
| 6 | 2004 | 29 | |
| 7 | 2010 | 28 | |
| 8 | 2007 | 9 | |
| 9 | 2007 | 9 | |
| 10 | 2004 | 4 |
About Andy Eberding
Andy Eberding is a scholar working on Molecular Biology, Oncology, Public Health, Environmental and Occupational Health, Biochemistry and Plant Science, having authored 10 papers that have together received 365 indexed citations. Recurring topics across this work include Ginseng Biological Effects and Applications (4 papers), Natural product bioactivities and synthesis (2 papers), Traditional and Medicinal Uses of Annonaceae (1 paper), Pharmaceutical Quality and Counterfeiting (1 paper), Biological Activity of Diterpenoids and Biflavonoids (1 paper), Phytochemistry and Biological Activities (1 paper), Medicinal Plants and Bioactive Compounds (1 paper) and Plant-derived Lignans Synthesis and Bioactivity (1 paper). The work is most often cited by research in Pharmacology (138 citations), Complementary and alternative medicine (42 citations), Molecular Biology (281 citations), Pharmacology (42 citations) and Endocrinology, Diabetes and Metabolism (35 citations). Andy Eberding has collaborated with scholars based in Canada, Germany and New Zealand. Frequent co-authors include Emma S. Tomlinson Guns, G.H.N. Towers, Dong Sheng Ming, William Jia, Ladan Fazli, Catherine A. Wood, Emma Tomlinson Guns, Hans Adomat, Sherwin Xie and Selvarani Vimalanathan. Their work appears in journals such as The Journal of Urology, Cancer Chemotherapy and Pharmacology, Phytotherapy Research, Analytical Biochemistry and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.